Tech Company Financing Transactions
SpringLeaf Therapeutics Funding Round
Excel Venture Management participated in a $4 million Series B funding round for SpringLeaf Therapeutics. The round was announced on 7/8/2011.
Transaction Overview
Company Name
Announced On
7/8/2011
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series B
Investors
Excel Venture Management (Enrico Petrillo)
Proceeds Purpose
With the support of our new and existing investors, SpringLeaf is well positioned to advance our proprietary program, transforming the way patients are treated.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
8 St. Mary's Street 601
Boston, MA 02215
USA
Boston, MA 02215
USA
Phone
Website
Email Address
Overview
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Garen Bohlin
Co-Founder
Yet-Ming Chiang
Co-Founder
Michael Cima
Browse more venture capital transactions:
Prev: 7/8/2011: Kickanotch venture capital transaction
Next: 7/8/2011: BlueCava venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs